Unknown

Dataset Information

0

Alzheimer's A? peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.


ABSTRACT: BACKGROUND: The amyloid-? (A?) peptide is the primary component of the extracellular senile plaques characteristic of Alzheimer's disease (AD). The metals hypothesis implicates redox-active copper ions in the pathogenesis of AD and the Cu(2+) coordination of various A? peptides has been widely studied. A number of disease-associated modifications involving the first 3 residues are known, including isomerisation, mutation, truncation and cyclisation, but are yet to be characterised in detail. In particular, A? in plaques contain a significant amount of truncated pyroglutamate species, which appear to correlate with disease progression. METHODOLOGY/PRINCIPAL FINDINGS: We previously characterised three Cu(2+)/A?1-16 coordination modes in the physiological pH range that involve the first two residues. Based upon our finding that the carbonyl of Ala2 is a Cu(2+) ligand, here we speculate on a hypothetical Cu(2+)-mediated intramolecular cleavage mechanism as a source of truncations beginning at residue 3. Using EPR spectroscopy and site-specific isotopic labelling, we have also examined four A? peptides with biologically relevant N-terminal modifications, A?1[isoAsp]-16, A?1-16(A2V), A?3-16 and A?3[pE]-16. The recessive A2V mutation preserved the first coordination sphere of Cu(2+)/A?, but altered the outer coordination sphere. Isomerisation of Asp1 produced a single dominant species involving a stable 5-membered Cu(2+) chelate at the amino terminus. The A?3-16 and A?3[pE]-16 peptides both exhibited an equilibrium between two Cu(2+) coordination modes between pH 6-9 with nominally the same first coordination sphere, but with a dramatically different pH dependence arising from differences in H-bonding interactions at the N-terminus. CONCLUSIONS/SIGNIFICANCE: N-terminal modifications significantly influence the Cu(2+) coordination of A?, which may be critical for alterations in aggregation propensity, redox-activity, resistance to degradation and the generation of the A?3-× (×?=?40/42) precursor of disease-associated A?3[pE]-x species.

SUBMITTER: Drew SC 

PROVIDER: S-EPMC3012727 | biostudies-literature | 2010

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.

Drew Simon C SC   Masters Colin L CL   Barnham Kevin J KJ  

PloS one 20101230 12


<h4>Background</h4>The amyloid-β (Aβ) peptide is the primary component of the extracellular senile plaques characteristic of Alzheimer's disease (AD). The metals hypothesis implicates redox-active copper ions in the pathogenesis of AD and the Cu(2+) coordination of various Aβ peptides has been widely studied. A number of disease-associated modifications involving the first 3 residues are known, including isomerisation, mutation, truncation and cyclisation, but are yet to be characterised in deta  ...[more]

Similar Datasets

| S-EPMC2928885 | biostudies-literature
| S-EPMC5522423 | biostudies-literature
| S-EPMC7539298 | biostudies-literature
| S-EPMC6296710 | biostudies-literature
| S-EPMC3368634 | biostudies-literature
| S-EPMC8597084 | biostudies-literature
| S-EPMC2100438 | biostudies-literature
| PRJEB42514 | ENA
| S-EPMC7957576 | biostudies-literature
| S-EPMC8267837 | biostudies-literature